Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
Clinical trial NCT03892525 · TERMINATED
Trial details
- NCT number
- NCT03892525
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2021-04-07
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.